- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06404866
Satisfaction With eMotion in a Diverse Group of Women
Study Overview
Detailed Description
This is a single-group study assessing participation satisfaction with the 10-week eMotion intervention. The eMotion intervention is based on feasibility testing of the successful in-person program with critical refinement to improve accessibility. eMotion has undergone subsequent content validity testing with intervention development, self-management, cardiovascular health, and health information technology delivery experts. eMotion teaches a carefully selected repertoire of emotion regulation strategies well suited for adults following a first cardiac event.
Participants will complete one lesson per week. The weekly education targets women and contains personalized content via diverse lesson narratives. Each week, participants listen to scripted sessions they can complete on their own time regarding each weekly topic (lasting about 30 minutes). At the end of the week, participants meet individually with a study team member virtually to discuss the same subject. The lessons will be comprised of rich emotion regulation strategies selected based on the efficacy and preferences of middle-aged and older adults. The 10 lessons covered are, 1) safe exercise guidelines and strategies, 2) why emotions matter and identifying emotions, 3) becoming an emotion detective, 4) mindful walking, 5) selecting and changing situations, 6) evaluating a challenge and responding, 7) choosing what to pay attention to, 8) thinking positively, 9) emotional responses for change, and 10) changing strategies and recognizing strengths.
Baseline and concluding surveys will be completed by participants that will take approximately 20 minutes. The baseline and concluding measures will help investigators characterize our sample and further understand risk factors that may contribute to dissatisfaction or confusion. After each week's lessons, each participant will be sent an individualized survey link to complete an IU RedCap survey with questions covering participant satisfaction with the eMotion intervention. The intervening surveys (weeks 2-9) should take approximately 10 minutes to complete each week.
Each week's content, including lessons, and surveys will last approximately 45-60 minutes, or 10 hours across the entire intervention period.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Eskenazi Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- First-time major cardiac event as documented in the medical record
- Lives independently
- Has at least mild symptoms of depression (determined by Patient Health Questionnaire-8 [PHQ-8] scores of 5 or greater) and/or at least mild symptoms of anxiety (determined by the General Anxiety Disorder [GAD-7] scores of 5 or greater).
Exclusion Criteria:
- Does not understand both spoken and written English
- In palliative care or hospice
- Legally blind
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: eMotion Intervention
This is a single-group study assessing participation satisfaction with the 10-week eMotion intervention.
The eMotion intervention is based on feasibility testing of the successful in-person program with critical refinement to improve accessibility.
eMotion has undergone subsequent content validity testing with intervention development, self-management, cardiovascular health, and health information technology delivery experts.
eMotion teaches a carefully selected repertoire of emotion regulation strategies well suited for adults following a first cardiac event.
|
Participants will complete one lesson per week.
The weekly education is targeted to women and contains personalized content via a variety of diverse lesson narratives.
Each week participants listen to scripted sessions they can complete on their own time regarding each of the weekly topics (lasting about 30 minutes).
At the end of the week, they then meet individually with a study team member virtually to discuss the same subject.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Distress-Depression and Anxiety Stress Scale
Time Frame: three months
|
Changes in the level of distress over time.
The minimum value (Normal):0 The maximum value (extremely severe): 42 Higher scores equate to worse outcome.
|
three months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical Activity
Time Frame: three months
|
Change in amount of time exercising at moderate or greater intensity
|
three months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kelly L Wierenga, PhD, Indiana University School of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19153
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Emotions
-
University of OstravaTechnical University of Ostrava; DAP ITCompleted
-
Duke UniversityNational Institute of Mental Health (NIMH); Mind and Life Institute, Hadley...Completed
-
Sys2DiagCentre National de la Recherche Scientifique, FranceNot yet recruiting
-
King's College LondonCommittee for ChildrenNot yet recruiting
-
Virginia Commonwealth UniversityCompleted
-
University of Colorado, BoulderCompletedSleep | Emotions
-
Centre Hospitalier Universitaire de BesanconUnknown
-
German Institute of Human NutritionRecruiting
-
University of MiamiInstitute of Educational Sciences (IES)Active, not recruitingEmotionsUnited States
-
Chang Gung Memorial HospitalUnknown
Clinical Trials on eMotion
-
University of DenverNational Institute of Mental Health (NIMH)Completed
-
Treatment InnovationsCompleted
-
Northwell HealthWithdrawn
-
Teachers College, Columbia UniversityRecruitingDepression | Anxiety | Distress, Emotional | Rumination | Self-Criticism | WorryUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute on Disability, Independent Living, and Rehabilitation...CompletedTraumatic Brain Injury | Executive Dysfunction | Emotion Dysregulation | Emotion DysfunctionUnited States
-
Teachers College, Columbia UniversityUniversity of MichiganCompletedDepression | Anxiety | Distress, Emotional | Emotional DysfunctionUnited States
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Northwestern UniversityUniversity of California, San FranciscoCompleted
-
Douglas MenninWeill Medical College of Cornell University; Kent State UniversityCompletedGeneralized Anxiety Disorder | Depression, Anxiety | Anxiety Disorders and Symptoms | Emotional DysfunctionUnited States
-
University of ExeterUniversity of GlasgowCompletedDepressive SymptomsUnited Kingdom